Major differences in organization and availability of health care and medicines for <scp>HIV/TB</scp> coinfected patients across <scp>E</scp>urope

Michael-Dieter Mansfeld(University of Copenhagen), Simona Tetradov(Spitalul Clinic Dr. Victor Babes), Leah Shepherd(University College London), Ole Kirk(University of Copenhagen), Anna Grzeszczuk(Medical University of Białystok), Aliaksandr Skrahin(Belarusian State Medical University), Anna Schultze(University College London), Frank A. Post(King's College Hospital NHS Foundation Trust), Hansjakob Furrer(University of Bern), Amanda Mocroft(University of Copenhagen), Jens Lundgren(Centre of Excellence for Health, Immunity and Infections), AM Panteleev(City Hospital No. 40), Robert F. Miller(University College Hospital), Daria Podlekareva(University of Copenhagen), N Bolokadze(AIDS and Clinical Immunology Research Center), JM Miró(Hospital Clínic de Barcelona), Indra Zeltiņa(University of Copenhagen), Alberto Matteelli(University of Brescia), AMW Efsen(University of Copenhagen)
HIV Medicine
May 11, 2015
10.1111/hiv.12256
Cited by 24

Related Papers

Industrial enzyme applications
|Current Opinion in Biotechnology|2002|1.5k
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
|JAMA|2016|1.4k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
|The Lancet|2019|1k
Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study
|AIDS|2003|987